ID1 and neoplasm: This translates the primary observation embedded in anti-Id vaccination protocols into the present day use of diversified prime and boost strategies to enhance anti-tumor immunity (Grosenbach et al., 2001; Monzavi-Karbassi et al., 2003; Nolz and Harty, 2011).